{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:56:20Z","timestamp":1793246180675,"version":"4.5.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Atrial fibrillation (AF) is the most common cardiac tachyarrhythmia and has a rising global prevalence. Given the increasing burden of AF-related symptoms and complications, new approaches to management are required. Anemia and iron deficiency are common conditions in patients with AF. Furthermore, emerging evidence suggests that the presence of anemia may be associated with worse outcome in these patients. The role of anemia and iron deficiency has been extensively explored in other cardiovascular states, such as heart failure and ischemic heart disease. In particular, the role of iron repletion amongst patients with heart failure is now an established treatment modality. However, despite the strong bidirectional inter-relationship between AF and heart failure, the implications of anemia and iron-deficiency in AF have been scarcely studied. This area is of mechanistic and clinical relevance given the potential that treatment of these conditions may improve symptoms and prognosis in the increasing number of individuals with AF. In this review, we summarise the current published literature on anemia and iron deficiency in patients with AF. We discuss AF complications such as stroke, bleeding, and heart failure, in addition to AF-related symptoms such as exercise intolerance, and the potential impact of anemia and iron deficiency on these. Finally, we summarize current research gaps on anemia, iron deficiency, and AF, and underscore potential research directions.<\/jats:p>","DOI":"10.1186\/s12872-022-02633-6","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T10:04:03Z","timestamp":1651658643000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Anemia and iron deficiency in patients with atrial fibrillation"],"prefix":"10.1186","volume":"22","author":[{"given":"Nicole","family":"Hanna-Rivero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel J.","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian D.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley M.","family":"Pitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis H.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashanthan","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1913-6675","authenticated-orcid":false,"given":"Christopher X.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,4]]},"reference":[{"key":"2633_CR1","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.ijcard.2012.12.093","volume":"167","author":"J Ball","year":"2013","unstructured":"Ball J, Carrington MJ, McMurray JJV, Stewart S. Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Int J Cardiol. 2013;167:1807\u201324.","journal-title":"Int J Cardiol"},{"key":"2633_CR2","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.hlc.2017.05.120","volume":"26","author":"CX Wong","year":"2017","unstructured":"Wong CX, Brown A, Tse HF, Albert CM, Kalman J, Marwick TH, Lau DH, Sanders P. Epidemiology of atrial fibrillation: the Australian and Asia-Pacific perspective. Heart Lung Circ. 2017;26:870\u20139.","journal-title":"Heart Lung Circ"},{"key":"2633_CR3","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","volume":"129","author":"SS Chugh","year":"2014","unstructured":"Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr, Zheng ZJ, Forouzanfar MH, Naghavi M, Mensah GA, Ezzati M, Murray CJ. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129:837\u201347.","journal-title":"Circulation"},{"key":"2633_CR4","doi-asserted-by":"publisher","first-page":"h7013","DOI":"10.1136\/bmj.h7013","volume":"532","author":"CA Emdin","year":"2016","unstructured":"Emdin CA, Wong CX, Hsiao AJ, Altman DG, Peters SA, Woodward M, Odutayo AA. Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies. BMJ. 2016;532:h7013.","journal-title":"BMJ"},{"key":"2633_CR5","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1161\/CIRCULATIONAHA.111.069450","volume":"125","author":"M Rienstra","year":"2012","unstructured":"Rienstra M, Lubitz SA, Mahida S, Magnani JW, Fontes JD, Sinner M, Van Gelder I, Ellinor P, Benjamin E. Symptoms and functional status of patients with atrial fibrillation state of the art and future research opportunities. Circulation. 2012;125:2933\u201343.","journal-title":"Circulation"},{"key":"2633_CR6","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1136\/heartjnl-2018-314471","volume":"105","author":"C Gallagher","year":"2019","unstructured":"Gallagher C, Hendriks JM, Giles L, Karnon J, Pham C, Elliott AD, Middeldorp ME, Mahajan R, Lau DH, Sanders P, Wong CX. Increasing trends in hospitalisations due to atrial fibrillation in Australia from 1993 to 2013. Heart. 2019;105:1358\u201363.","journal-title":"Heart"},{"key":"2633_CR7","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/archinternmed.2012.878","volume":"172","author":"CX Wong","year":"2012","unstructured":"Wong CX, Brooks AG, Leong DP, Roberts-Thomson KC, Sanders P. The increasing burden of atrial fibrillation compared to heart failure and myocardial infarction: a 15-year study of all hospitalizations in Australia. Arch Intern Med. 2012;172:739\u201341.","journal-title":"Arch Intern Med"},{"key":"2633_CR8","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/jce.14898","volume":"32","author":"SJ Tu","year":"2021","unstructured":"Tu SJ, Hanna-Rivero N, Elliott AD, Clarke N, Huang S, Pitman BM, Gallagher C, Linz D, Mahajan R, Lau DH, Sanders P, Wong CX. Associations of anemia with stroke, bleeding, and mortality in atrial fibrillation: a systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2021;32:686\u201394.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2633_CR9","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.1093\/eurheartj\/ehz155","volume":"40","author":"AN Bonde","year":"2019","unstructured":"Bonde AN, Blanche P, Staerk L, Gerds TA, Gundlund A, Gislason G, Torp-Pedersen C, Lip GYH, Hlatky MA, Olesen JB. Oral anticoagulation among atrial fibrillation patients with anemia: an observational cohort study. Eur Heart J. 2019;40:3782\u201390.","journal-title":"Eur Heart J"},{"key":"2633_CR10","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/jth.12874","volume":"13","author":"BD Westenbrink","year":"2015","unstructured":"Westenbrink BD, Alings M, Connolly SJ, Eikelboom J, Ezekowitz MD, Oldgren J, Yang S, Pongue J, Yusuf S, Wallentin L, van Gilst WH. Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE-LY trial. J Thromb Haemost. 2015;13:699\u2013707.","journal-title":"J Thromb Haemost"},{"key":"2633_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ahj.2016.12.008","volume":"185","author":"BD Westenbrink","year":"2017","unstructured":"Westenbrink BD, Alings M, Granger CB, Alexander JH, Lopes RD, Hylek EM, Thomas L, Wojdyla DM, Hanna M, Keltai M, Steg PG, De Caterina R, Wallentin L, van Gilst WH. Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Am Heart J. 2017;185:140\u20139.","journal-title":"Am Heart J"},{"key":"2633_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56847-4","volume":"10","author":"L Woo-Hyun","year":"2020","unstructured":"Woo-Hyun L, Eue-Keun C, Kyung-Do H, So-Ryoung L, Myung-Jin C, Seil O. Impact of hemoglobin levels and their dynamic changes on the risk of atrial fibrillation: a nationwide population-based study. Sci Rep. 2020;10:1\u20138.","journal-title":"Sci Rep"},{"key":"2633_CR13","doi-asserted-by":"publisher","first-page":"P4271","DOI":"10.1093\/eurheartj\/eht309.P4271","volume":"34","author":"DZ Xu","year":"2013","unstructured":"Xu DZ, Murakoshi N, Sairenchi T, Irie F, Igarashi M, Tomizawa T, Yamaguchi I, Iso H, Ota H, Aonuma K. Reduced kidney function and anemia as risk factors for new onset AF. Eur Heart J. 2013;34:P4271\u2013P4271.","journal-title":"Eur Heart J"},{"key":"2633_CR14","first-page":"100507","volume":"27","author":"M Kim","year":"2020","unstructured":"Kim M, Hong M, Kim JY, Kim IS, Yu HT, Kim TH, Uhm JS, Joung B, Lee MH, Pak HN. Clinical relationship between anemia and atrial fibrillation recurrence after catheter ablation without genetic background. Int J Cardiol Heart Vasc. 2020;27:100507.","journal-title":"Int J Cardiol Heart Vasc"},{"key":"2633_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2217\/fca.10.110","volume":"7","author":"S Von Haehling","year":"2011","unstructured":"Von Haehling S, Jankowska E, Anker S. Anemia in heart failure: an overview of current concepts. Future Cardiol. 2011;7:119\u201329.","journal-title":"Future Cardiol"},{"key":"2633_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.hlc.2015.06.827","volume":"25","author":"CCY Wong","year":"2016","unstructured":"Wong CCY, Ng ACC, Kritharides L, Sindone AP. Iron deficiency in heart failure: looking beyond anemia. Heart Lung Circ. 2016;25:209\u201316.","journal-title":"Heart Lung Circ"},{"key":"2633_CR17","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","volume":"31","author":"EA Jankowska","year":"2010","unstructured":"Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, Borodulin-Nadzieja L, Banasiak W, Polonski L, Filippatos G, McMurray JJV, Anker SD, Ponikowski P. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J. 2010;31:1872\u201380.","journal-title":"Eur Heart J"},{"key":"2633_CR18","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonz\u00e1lez-Juanatey JR, Harjola V-P, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Filippatos G, McMurray JJV, Aboyans V, Achenbach S, Agewall S, Al-Attar N, Atherton JJ, Bauersachs J, John Camm A, Carerj S, Ceconi C, Coca A, Elliott P, Erol \u00c7, Ezekowitz J, Fern\u00e1ndez-Golf\u00edn C, Fitzsimons D, Guazzi M, Guenoun M, Hasenfuss G, Hindricks G, Hoes AW, Iung B, Jaarsma T, Kirchhof P, Knuuti J, Kolh P, Konstantinides S, Lainscak M, Lancellotti P, Lip GYH, Maisano F, Mueller C, Petrie MC, Piepoli MF, Priori SG, Torbicki A, Tsutsui H, van Veldhuisen DJ, Windecker S, Yancy C, Zamorano JL, Badimon L, Bar\u00f3n-Esquivias G, Baumgartner H, Bax JJ, Dean V, Gaemperli O, Roffi M, Vaz Carneiro A, Sisakian HS, Isayev E, Kurlianskaya A, Mullens W, Tokmakova M, Agathangelou P, Melenovsky V, Wiggers H, Hassanein M, Uuetoa T, Lommi J, Kostovska ES, Juilli\u00e8re Y, Aladashvili A, Luchner A, Chrysohoou C, Nyolczas N, Thorgeirsson G, Marc Weinstein J, Di Lenarda A, Aidargaliyeva N, Bajraktari G, Beishenkulov M, Kamzola G, Abdel-Massih T, \u010celutkien\u0117 J, Noppe S, Cassar A, Vataman E. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37:2129\u2013200.","journal-title":"Eur Heart J"},{"key":"2633_CR19","doi-asserted-by":"publisher","first-page":"i4482","DOI":"10.1136\/bmj.i4482","volume":"354","author":"A Odutayo","year":"2016","unstructured":"Odutayo A, Wong C, Hsiao A, Hopewell S, Altman DG, Emdin C. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ Br Med J. 2016;354:i4482.","journal-title":"BMJ Br Med J"},{"key":"2633_CR20","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.clinthera.2014.08.002","volume":"36","author":"DH Lau","year":"2014","unstructured":"Lau DH, Kalman J, Sanders P. Management of recent-onset sustained atrial fibrillation: pharmacologic and nonpharmacologic strategies. Clin Ther. 2014;36:1151\u20139.","journal-title":"Clin Ther"},{"key":"2633_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jacc.2010.09.026","volume":"57","author":"SH Hohnloser","year":"2011","unstructured":"Hohnloser SH. Stroke prevention versus bleeding risk in atrial fibrillation: a clinical dilemma. J Am Coll Cardiol. 2011;57:181\u20133.","journal-title":"J Am Coll Cardiol"},{"key":"2633_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/JCN.0000000000000421","volume":"33","author":"KT Gleason","year":"2018","unstructured":"Gleason KT, Nazarian S, Dennison Himmelfarb CR. Atrial fibrillation symptoms and sex, race, and psychological distress: a literature review. J Cardiovasc Nurs. 2018;33:137\u201343.","journal-title":"J Cardiovasc Nurs"},{"key":"2633_CR23","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/j.1540-8159.2005.00171.x","volume":"28","author":"SF Sears","year":"2005","unstructured":"Sears SF, Serber ER, Alvarez LG, Schwartzman DS, Hoyt RH, Ujhelyi MR. Understanding atrial symptom reports: objective versus subjective predictors. Pacing Clin Electrophysiol. 2005;28:801\u20137.","journal-title":"Pacing Clin Electrophysiol"},{"key":"2633_CR24","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1093\/eurheartj\/ehp046","volume":"30","author":"A Goette","year":"2009","unstructured":"Goette A, Bukowska A, Dobrev D, Pfeiffenberger J, Morawietz H, Strugala D, Wiswedel I, Rohl FW, Wolke C, Bergmann S, Bramlage P, Ravens U, Lendeckel U. Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles. Eur Heart J. 2009;30:1411\u201320.","journal-title":"Eur Heart J"},{"key":"2633_CR25","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/S0735-1097(97)00254-4","volume":"30","author":"DM Clark","year":"1997","unstructured":"Clark DM, Plumb VJ, Epstein AE, Kay GN. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol. 1997;30:1039\u201345.","journal-title":"J Am Coll Cardiol"},{"key":"2633_CR26","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/S0002-9149(97)89297-1","volume":"78","author":"EG Daoud","year":"1996","unstructured":"Daoud EG, Weiss R, Bahu M, Knight BP, Bogun F, Goyal R, Harvey M, Strickberger SA, Man KC, Morady F. Effect of an irregular ventricular rhythm on cardiac output. Am J Cardiol. 1996;78:1433\u20136.","journal-title":"Am J Cardiol"},{"key":"2633_CR27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/oxfordjournals.eurheartj.a059687","volume":"11","author":"CP Lau","year":"1990","unstructured":"Lau CP, Leung WH, Wong CK, Cheng CH. Haemodynamics of induced atrial fibrillation: a comparative assessment with sinus rhythm, atrial and ventricular pacing. Eur Heart J. 1990;11:219\u201324.","journal-title":"Eur Heart J"},{"key":"2633_CR28","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/0002-9343(64)90160-3","volume":"36","author":"NS Skinner Jr","year":"1964","unstructured":"Skinner NS Jr, Mitchell JH, Wallace AG, Sarnoff SJ. Hemodynamic consequences of atrial fibrillation at constant ventricular rates. Am J Med. 1964;36:342\u201350.","journal-title":"Am J Med"},{"key":"2633_CR29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/oxfordjournals.ndt.a027970","volume":"15","author":"F Metivier","year":"2000","unstructured":"Metivier F, Marchais SJ, Guerin AP, Pannier B, London GM. Pathophysiology of anemia: focus on the heart and blood vessels. Nephrol Dial Transplant. 2000;15:14\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"2633_CR30","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jacc.2006.03.051","volume":"48","author":"SN Singh","year":"2006","unstructured":"Singh SN, Tang XC, Singh BN, Dorian P, Reda DJ, Harris CL, Fletcher RD, Sharma SC, Atwood JE, Jacobson AK, Lewis HD, Lopez B, Raisch DW, Ezekowitz MD. Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation. J Am Coll Cardiol. 2006;48:721\u201330.","journal-title":"J Am Coll Cardiol"},{"key":"2633_CR31","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1161\/CIRCHEARTFAILURE.111.965186","volume":"5","author":"AM Swank","year":"2012","unstructured":"Swank AM, Horton J, Fleg JL, Fonarow GC, Keteyian S, Goldberg L, Wolfel G, Handberg EM, Bensimhon D, Illiou MC, Vest M, Ewald G, Blackburn G, Leifer E, Cooper L, Kraus WE. Modest increase in peak VO2 is related to better clinical outcomes in chronic heart failure patients: results from heart failure and a controlled trial to investigate outcomes of exercise training. Circ Heart Fail. 2012;5:579\u201385.","journal-title":"Circ Heart Fail"},{"key":"2633_CR32","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/00008483-200011000-00003","volume":"20","author":"L Vanhees","year":"2000","unstructured":"Vanhees L, Schepers D, Defoor J, Brusselle S, Tchursh N, Fagard R. Exercise performance and training in cardiac patients with atrial fibrillation. J Cardiopulm Rehabil. 2000;20:346.","journal-title":"J Cardiopulm Rehabil"},{"key":"2633_CR33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ijcard.2006.03.034","volume":"116","author":"F Hegbom","year":"2007","unstructured":"Hegbom F, Stavem K, Sire S, Heldal M, Orning OM, Gjesdal K. Effects of short-term exercise training on symptoms and quality of life in patients with chronic atrial fibrillation. Int J Cardiol. 2007;116:86\u201392.","journal-title":"Int J Cardiol"},{"key":"2633_CR34","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1111\/jce.14149","volume":"30","author":"Y Katsumata","year":"2019","unstructured":"Katsumata Y, Tamura Y, Kimura T, Kohsaka S, Sadahiro T, Nishiyama T, Aizawa Y, Azuma K, Fukuda K, Takatsuki S. A high BNP level predicts an improvement in exercise tolerance after a successful catheter ablation of persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2019;30:2283\u201390.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2633_CR35","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1111\/jce.12467","volume":"25","author":"S Mohanty","year":"2014","unstructured":"Mohanty S, Santangeli P, Mohanty P, Biase LD, Holcomb S, Trivedi C, Bai R, Burkhardt D, Hongo R, Hao S, Beheiry S, Santoro F, Forleo G, Gallinghouse JG, Horton R, Sanchez JE, Bailey S, Hranitzky PM, Zagrodzky J, Natale A. Catheter ablation of asymptomatic longstanding persistent atrial fibrillation: impact on quality of life, exercise performance, arrhythmia perception, and arrhythmia-free survival. J Cardiovasc Electrophysiol. 2014;25:1057\u201364.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2633_CR36","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1056\/NEJMoa041705","volume":"352","author":"BN Singh","year":"2005","unstructured":"Singh BN, Singh SN, Reda DJ, Tang XC, Lopez B, Harris CL, Fletcher RD, Sharma SC, Atwood JE, Jacobson AK, Lewis HD, Raisch DW, Ezekowitz MD. Amiodarone versus sotalol for atrial fibrillation. N Engl J Med. 2005;352:1861.","journal-title":"N Engl J Med"},{"key":"2633_CR37","unstructured":"Australian health survey: biomedical results for chronic diseases, 2011\u201312; 2013."},{"key":"2633_CR38","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1017\/S1368980008002401","volume":"12","author":"E McLean","year":"2009","unstructured":"McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anemia, WHO vitamin and mineral nutrition information system, 1993\u20132005. Public Health Nutr. 2009;12:444\u201354.","journal-title":"Public Health Nutr"},{"key":"2633_CR39","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/ajh.23598","volume":"89","author":"LT Goodnough","year":"2014","unstructured":"Goodnough LT, Schrier SL. Evaluation and management of anemia in the elderly. Am J Hematol. 2014;89:88\u201396.","journal-title":"Am J Hematol"},{"key":"2633_CR40","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1182\/blood-2004-05-1812","volume":"104","author":"JM Guralnik","year":"2004","unstructured":"Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004;104:2263.","journal-title":"Blood"},{"key":"2633_CR41","doi-asserted-by":"publisher","first-page":"525","DOI":"10.5694\/j.1326-5377.2010.tb04038.x","volume":"193","author":"SR Pasricha","year":"2010","unstructured":"Pasricha SR, Flecknoe-Brown SC, Allen KJ, Gibson PR, McMahon LP, Olynyk JK, Roger SD, Savoia HF, Tampi R, Thomson AR, Wood EM, Robinson KL. Diagnosis and management of iron deficiency anemia: a clinical update. Med J Aust. 2010;193:525\u201332.","journal-title":"Med J Aust"},{"key":"2633_CR42","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/ajcn\/74.6.776","volume":"74","author":"P Adou","year":"2001","unstructured":"Adou P, Davidsson L, Cook J, Harrell R. Prevalence of iron deficiency with and without concurrent anemia in population groups with high prevalences of malaria and other infections: a study in Cote d\u2019Ivoire. Am J Clin Nutr. 2001;74:776\u201382.","journal-title":"Am J Clin Nutr"},{"key":"2633_CR43","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1017\/S0007114515004912","volume":"115","author":"EJ Callander","year":"2016","unstructured":"Callander EJ, Schofield DJ. Is there a mismatch between who gets iron supplementation and who needs it? A cross-sectional study of iron supplements, iron deficiency anemia and socio-economic status in Australia. Br J Nutr. 2016;115:703\u20138.","journal-title":"Br J Nutr"},{"key":"2633_CR44","first-page":"40","volume":"17","author":"F Ahmed","year":"2008","unstructured":"Ahmed F, Coyne T, Dobson A, McClintock C. Iron status among Australian adults: findings of a population based study in Queensland, Australia. Asia Pac J Clin Nutr. 2008;17:40.","journal-title":"Asia Pac J Clin Nutr"},{"key":"2633_CR45","doi-asserted-by":"publisher","first-page":"R182","DOI":"10.1186\/ar4012","volume":"14","author":"K Vanarsa","year":"2012","unstructured":"Vanarsa K, Ye Y, Han J, Xie C, Mohan C, Wu T. Inflammation associated anemia and ferritin as disease markers in SLE. Arthritis Res Ther. 2012;14:R182.","journal-title":"Arthritis Res Ther"},{"key":"2633_CR46","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.1182\/blood.V90.12.4979","volume":"90","author":"TN Tran","year":"1997","unstructured":"Tran TN, Eubanks SK, Schaffer KJ, Zhou CY, Linder MC. Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron. Blood. 1997;90:4979.","journal-title":"Blood"},{"key":"2633_CR47","unstructured":"Diagnosis and investigation of iron deficiency anemia. 2017."},{"key":"2633_CR48","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jacc.2017.12.027","volume":"71","author":"BML Rocha","year":"2018","unstructured":"Rocha BML, Cunha GJL, Menezes Falc\u00e3o LF. The burden of iron deficiency in heart failure: therapeutic approach. J Am Coll Cardiol. 2018;71:782\u201393.","journal-title":"J Am Coll Cardiol"},{"key":"2633_CR49","doi-asserted-by":"crossref","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonz\u00e1lez-Juanatey JR, Harjola V-P, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Group ESD. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129\u20132200.","DOI":"10.1093\/eurheartj\/ehw128"},{"key":"2633_CR50","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jchf.2018.07.015","volume":"7","author":"S Von Haehling","year":"2019","unstructured":"Von Haehling S, Ebner N, Evertz R, Ponikowski P, Anker SD. Iron deficiency in heart failure. JACC Heart Fail. 2019;7:36\u201346.","journal-title":"JACC Heart Fail"},{"key":"2633_CR51","doi-asserted-by":"publisher","first-page":"e001012","DOI":"10.1136\/openhrt-2019-001012","volume":"6","author":"AL Beale","year":"2019","unstructured":"Beale AL, Warren JL, Roberts N, Meyer P, Townsend NP, Kaye D. Iron deficiency in heart failure with preserved ejection fraction: a systematic review and meta-analysis. Open Heart. 2019;6:e001012.","journal-title":"Open Heart"},{"key":"2633_CR52","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.acvd.2016.06.003","volume":"110","author":"J Pozzo","year":"2017","unstructured":"Pozzo J, Fournier P, Delmas C, Vervueren P-L, Roncalli J, Elbaz M, Galinier M, Lairez O. Absolute iron deficiency without anemia in patients with chronic systolic heart failure is associated with poorer functional capacity. Arch Cardiovasc Dis. 2017;110:99\u2013105.","journal-title":"Arch Cardiovasc Dis"},{"key":"2633_CR53","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","volume":"136","author":"DJ Van Veldhuisen","year":"2017","unstructured":"Van Veldhuisen DJ, Ponikowski P, van Der Meer P, Metra M, B\u00f6hm M, Doletsky A, Voors AA, Macdougall IC, Anker SD, Roubert B, Zakin L, Cohen-Solal A. Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency. Circulation. 2017;136:1374.","journal-title":"Circulation"},{"key":"2633_CR54","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/ejhf.823","volume":"20","author":"SD Anker","year":"2018","unstructured":"Anker SD, Kirwan BA, van Veldhuisen DJ, Filippatos G, Comin-Colet J, Ruschitzka F, L\u00fcscher TF, Arutyunov GP, Motro M, Mori C, Roubert B, Pocock SJ, Ponikowski P. Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis. Eur J Heart Fail. 2018;20:125\u201333.","journal-title":"Eur J Heart Fail"},{"key":"2633_CR55","doi-asserted-by":"crossref","unstructured":"Ponikowski P, Kirwan BA, Anker SD, McDonagh T, Dorobantu M, Drozdz J, Fabien V, Filippatos G, Gohring UM, Keren A, Khintibidze I, Kragten H, Martinez FA, Metra M, Milicic D, Nicolau JC, Ohlsson M, Parkhomenko A, Pascual-Figal DA, Ruschitzka F, Sim D, Skouri H, van der Meer P, Lewis BS, Comin-Colet J, von Haehling S, Cohen-Solal A, Danchin N, Doehner W, Dargie HJ, Motro M, Butler J, Friede T, Jensen KH, Pocock S, Jankowska EA, investigators A-A. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet. 2020;396:1895\u20131904.","DOI":"10.1016\/S0140-6736(20)32339-4"},{"key":"2633_CR56","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMra041809","volume":"352","author":"G Weiss","year":"2005","unstructured":"Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352:1011.","journal-title":"N Engl J Med"},{"key":"2633_CR57","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.jacc.2011.04.040","volume":"58","author":"DO Okonko","year":"2011","unstructured":"Okonko DO, Mandal AKJ, Missouris CG, Poole-Wilson PA. Disordered iron homeostasis in chronic heart failure. J Am Coll Cardiol. 2011;58:1241\u201351.","journal-title":"J Am Coll Cardiol"},{"key":"2633_CR58","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1172\/JCI200420945","volume":"113","author":"E Nemeth","year":"2004","unstructured":"Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Investig. 2004;113:1271\u20136.","journal-title":"J Clin Investig"},{"key":"2633_CR59","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1089\/jir.1998.18.555","volume":"18","author":"W Jelkmann","year":"1998","unstructured":"Jelkmann W. Proinflammatory cytokines lowering erythropoietin production. J Interferon Cytokine Res. 1998;18:555\u20139.","journal-title":"J Interferon Cytokine Res"},{"issue":"7","key":"2633_CR60","doi-asserted-by":"publisher","first-page":"e0158599","DOI":"10.1371\/journal.pone.0158599","volume":"11","author":"N Lofruthe","year":"2016","unstructured":"Lofruthe N, Gallitz I, Traeger L, Baumer N, Schulze I, Kuhlmann T, Muller-Tidow C, Steinbicker AU. Intravenous iron carboxymaltose as a potential therapeutic in anemia of inflammation. PLoS ONE. 2016;11(7):e0158599.","journal-title":"PLoS ONE"},{"key":"2633_CR61","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/ejhf.236","volume":"17","author":"T McDonagh","year":"2015","unstructured":"McDonagh T, Macdougall IC. Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral? Eur J Heart Fail. 2015;17:248\u201362.","journal-title":"Eur J Heart Fail"},{"key":"2633_CR62","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0002-9149(02)03373-8","volume":"91","author":"WH Maisel","year":"2003","unstructured":"Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol. 2003;91:2\u20138.","journal-title":"Am J Cardiol"},{"key":"2633_CR63","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nrcardio.2015.2","volume":"12","author":"Y-F Hu","year":"2015","unstructured":"Hu Y-F, Chen Y-J, Lin Y-J, Chen S-A. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015;12:230\u201343.","journal-title":"Nat Rev Cardiol"},{"key":"2633_CR64","doi-asserted-by":"publisher","first-page":"14991","DOI":"10.1074\/jbc.RA119.009578","volume":"294","author":"AJ Schwartz","year":"2019","unstructured":"Schwartz AJ, Converso-Baran K, Michele DE, Shah YM. A genetic mouse model of severe iron deficiency anemia reveals tissue-specific transcriptional stress responses and cardiac remodeling. J Biol Chem. 2019;294:14991\u20135002.","journal-title":"J Biol Chem"},{"key":"2633_CR65","doi-asserted-by":"publisher","first-page":"e004700","DOI":"10.1136\/bmjopen-2013-004700","volume":"4","author":"M Puurunen","year":"2014","unstructured":"Puurunen M, Kiviniemi T, Nammas W, Schlitt A, Rubboli A, Nyman K, Karjalainen P, Kirchhof P, Lip GYH, Airaksinen JKE. Impact of anemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry. BMJ Open. 2014;4:e004700.","journal-title":"BMJ Open"},{"key":"2633_CR66","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ahj.2016.12.008","volume":"185","author":"BD Westenbrink","year":"2017","unstructured":"Westenbrink BD, van Gilst WH, Lopes RD, Thomas L, Wojdyla DM. Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Am Heart J. 2017;185:140\u20139.","journal-title":"Am Heart J"},{"key":"2633_CR67","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/clc.23559","volume":"44","author":"R Krittayaphong","year":"2021","unstructured":"Krittayaphong R, Pumprueg S, Thongsri T, Wiwatworapan W, Choochunklin T, Kaewkumdee P, Yindeengam A, Investigators C-A. Impact of anemia on clinical outcomes of patients with atrial fibrillation: the COOL-AF registry. Clin Cardiol. 2021;44:415\u201323.","journal-title":"Clin Cardiol"},{"key":"2633_CR68","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.amjcard.2021.06.045","volume":"157","author":"K Hashimoto","year":"2021","unstructured":"Hashimoto K, Kimura T, Ikemura N, Katsumata Y, Fujisawa T, Miyama H, Yamashita T, Nakamura I, Mano Y, Oki T, Fukuda K, Kohsaka S, Takatsuki S. Burden of mild (<13 g\/dl) anemia in patients with atrial fibrillation (a report from a multicenter registry with patient-reported outcomes). Am J Cardiol. 2021;157:48\u201355.","journal-title":"Am J Cardiol"},{"key":"2633_CR69","doi-asserted-by":"crossref","unstructured":"An Y, Ogawa H, Esato M, Ishii M, Iguchi M, Masunaga N, Fujino A, Ide Y, Hamatani Y, Doi K, Ikeda S, Ishigami K, Tsuji H, Wada H, Hasegawa K, Abe M, Lip GYH, Akao M, Fushimi AFRI. Cardiovascular events and mortality in patients with atrial fibrillation and anemia (from the Fushimi AF registry). Am J Cardiol. 2020;134:74\u201382.","DOI":"10.1016\/j.amjcard.2020.08.009"},{"key":"2633_CR70","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1093\/eurheartj\/ehw233","volume":"37","author":"J-P Bassand","year":"2016","unstructured":"Bassand J-P, Accetta G, Camm AJ, Cools F, Fitzmaurice DA, Fox KAA, Goldhaber SZ, Goto S, Haas S, Hacke W, Kayani G, Mantovani LG, Misselwitz F, Ten Cate H, Turpie AGG, Verheugt FWA, Kakkar AK, Investigators G-A. Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF. Eur Heart J. 2016;37:2882\u20139.","journal-title":"Eur Heart J"},{"key":"2633_CR71","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/ehjqcco\/qcy033","volume":"5","author":"Y An","year":"2019","unstructured":"An Y, Ogawa H, Yamashita Y, Ishii M, Iguchi M, Masunaga N, Esato M, Tsuji H, Wada H, Hasegawa K, Abe M, Lip GYH, Akao M. Causes of death in Japanese patients with atrial fibrillation: the Fushimi Atrial Fibrillation Registry. Eur Heart J Qual Care Clin Outcomes. 2019;5:35\u201342.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2633_CR72","doi-asserted-by":"crossref","unstructured":"Anker SD, Voors A, Okonko D, Clark AL, James MK, von Haehling S, Kjekshus J, Ponikowski P, Dickstein K, for the OI. Prevalence, incidence, and prognostic value of anemia in patients after an acute myocardial infarction: data from the OPTIMAAL trial. Eur Heart J. 2009;30:1331\u20131339.","DOI":"10.1093\/eurheartj\/ehp116"},{"key":"2633_CR73","first-page":"103","volume":"46","author":"M Keskin","year":"2018","unstructured":"Keskin M, Ural D, Altay S, Argan O, B\u00f6rkl\u00fc EB, Kozan \u00d6. Iron deficiency and hematinic deficiencies in atrial fibrillation: a new insight into comorbidities. Turk Kardiyoloji Dernegi arsivi: Turk Kardiyoloji Derneginin yayin organidir. 2018;46:103.","journal-title":"Turk Kardiyoloji Dernegi arsivi: Turk Kardiyoloji Derneginin yayin organidir"},{"key":"2633_CR74","doi-asserted-by":"publisher","first-page":"899","DOI":"10.2169\/internalmedicine.9554-17","volume":"57","author":"R Imai","year":"2018","unstructured":"Imai R, Higuchi T, Morimoto M, Koyamada R, Okada S. Iron deficiency anemia due to the long-term use of a proton pump inhibitor. Internal Med (Tokyo, Japan). 2018;57:899.","journal-title":"Internal Med (Tokyo, Japan)"},{"key":"2633_CR75","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S0140-6736(15)60865-0","volume":"387","author":"A Lopez","year":"2016","unstructured":"Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anemia. Lancet. 2016;387:907\u201316.","journal-title":"Lancet"},{"key":"2633_CR76","doi-asserted-by":"crossref","unstructured":"Minhas AMK, Sagheer S, Shekhar R, Sheikh AB, Nazir S, Ullah W, Khan MZ, Shahid I, Dani SS, Michos ED, Fudim M. Trends and inpatient outcomes of primary atrial fibrillation hospitalizations with underlying iron deficiency anemia: an analysis of the national inpatient sample database from 2004\u20132018. Curr Probl Cardiol. 2021;101001.","DOI":"10.1016\/j.cpcardiol.2021.101001"},{"key":"2633_CR77","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1378\/chest.130.5.1390","volume":"130","author":"TI Shireman","year":"2006","unstructured":"Shireman TI, Mahnken JD, Howard PA, Kresowik TF, Hou Q, Ellerbeck EF. Development of a contemporary bleeding risk model for elderly warfarin recipients. Chest. 2006;130:1390\u20136.","journal-title":"Chest"},{"key":"2633_CR78","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.ahj.2009.03.009","volume":"157","author":"S Sharma","year":"2009","unstructured":"Sharma S, Gage BF, Deych E, Rich MW. Anemia: an independent predictor of death and hospitalizations among elderly patients with atrial fibrillation. Am Heart J. 2009;157:1057\u201363.","journal-title":"Am Heart J"},{"key":"2633_CR79","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1253\/circj.CJ-11-0015","volume":"75","author":"SJ Park","year":"2011","unstructured":"Park SJ, Lee SC, Jang SY, Chang SA, Choi JO, Park SW, Oh JK. E\/e\u2019 ratio is a strong prognostic predictor of mortality in patients with non-valvular atrial fibrillation with preserved left ventricular systolic function. Circ J. 2011;75:2350\u20136.","journal-title":"Circ J"},{"key":"2633_CR80","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.amjcard.2012.04.049","volume":"110","author":"S Suzuki","year":"2012","unstructured":"Suzuki S, Sagara K, Otsuka T, Matsuno S, Funada R, Uejima T, Oikawa Y, Yajima J, Koike A, Nagashima K, Kirigaya H, Sawada H, Aizawa T, Yamashita T. A new scoring system for evaluating the risk of heart failure events in japanese patients with atrial fibrillation. Am J Cardiol. 2012;110:678\u201382.","journal-title":"Am J Cardiol"},{"key":"2633_CR81","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1161\/CIRCEP.112.972869","volume":"5","author":"GY Lip","year":"2012","unstructured":"Lip GY, Banerjee A, Lagrenade I, Lane DA, Taillandier S, Fauchier L. Assessing the risk of bleeding in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation project. Circ Arrhythm Electrophysiol. 2012;5:941\u20138.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2633_CR82","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","volume":"33","author":"L Friberg","year":"2012","unstructured":"Friberg L, Rosenqvist M, Lip GY. Evaluation of risk stratification schemes for ischemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J. 2012;33:1500\u201310.","journal-title":"Eur Heart J"},{"key":"2633_CR83","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1160\/TH11-08-0524","volume":"107","author":"S Manzano-Fernandez","year":"2012","unstructured":"Manzano-Fernandez S, Cambronero F, Caro-Martinez C, Hurtado-Martinez JA, Marin F, Pastor-Perez FJ, Mateo-Martinez A, Sanchez-Martinez M, Pinar-Bermudez E, Valdes M. Mild kidney disease as a risk factor for major bleeding in patients with atrial fibrillation undergoing percutaneous coronary stenting. Thromb Haemost. 2012;107:51\u20138.","journal-title":"Thromb Haemost"},{"key":"2633_CR84","first-page":"846","volume":"35","author":"K Takabayashi","year":"2014","unstructured":"Takabayashi K, Takagi D, Hamatani Y, Unoki T, Esato M, Chun Y, Wada H, Hasegawa K, Abe M, Akao M. Incidence of hospitalization for heart failure in atrial fibrillation patients with anemia: one-year follow-up of the Fushimi AF Registry. Eur Heart J. 2014;35:846.","journal-title":"Eur Heart J"},{"key":"2633_CR85","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jacc.2013.11.013","volume":"63","author":"SG Goodman","year":"2014","unstructured":"Goodman SG, Wojdyla DM, Piccini JP, White HD, Paolini JF, Nessel CC, Berkowitz SD, Mahaffey KW, Patel MR, Sherwood MW, Becker RC, Halperin JL, Hacke W, Singer DE, Hankey GJ, Breithardt G, Fox KA, Califf RM, Investigators RA. Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation). J Am Coll Cardiol. 2014;63:891\u2013900.","journal-title":"J Am Coll Cardiol"},{"key":"2633_CR86","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/j.jacc.2015.09.024","volume":"66","author":"MW Sherwood","year":"2015","unstructured":"Sherwood MW, Nessel CC, Hellkamp AS, Mahaffey KW, Piccini JP, Suh EY, Becker RC, Singer DE, Halperin JL, Hankey GJ, Berkowitz SD, Fox KAA, Patel MR. Gastrointestinal bleeding in patients with atrial fibrillation treated with rivaroxaban or warfarin: ROCKET AF trial. J Am Coll Cardiol. 2015;66:2271\u201381.","journal-title":"J Am Coll Cardiol"},{"key":"2633_CR87","doi-asserted-by":"publisher","first-page":"618","DOI":"10.7150\/ijms.11924","volume":"12","author":"WH Lee","year":"2015","unstructured":"Lee WH, Hsu PC, Chu CY, Lee HH, Lee MK, Lee CS, Yen HW, Lin TH, Voon WC, Lai WT, Sheu SH, Su HM. Anemia as an independent predictor of adverse cardiac outcomes in patients with atrial fibrillation. Int J Med Sci. 2015;12:618\u201324.","journal-title":"Int J Med Sci"},{"key":"2633_CR88","first-page":"3258","volume":"36","author":"EC O'Brien","year":"2015","unstructured":"O\u2019Brien EC, Simon DN, Thomas LE, Hylek EM, Gersh BJ, Ansell JE, Kowey PR, Mahaffey KW, Chang P, Fonarow GC, Pencina MJ, Piccini JP, Peterson ED. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation. Eur Heart J. 2015;36:3258\u201364.","journal-title":"Eur Heart J"},{"key":"2633_CR89","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jamacardio.2015.0345","volume":"1","author":"JA Dodson","year":"2016","unstructured":"Dodson JA, Petrone A, Gagnon DR, Tinetti ME, Krumholz HM, Gaziano JM. Incidence and determinants of traumatic intracranial bleeding among older veterans receiving warfarin for atrial fibrillation. JAMA Cardiol. 2016;1:65\u201372.","journal-title":"JAMA Cardiol"},{"key":"2633_CR90","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jjcc.2015.12.003","volume":"68","author":"M Hori","year":"2016","unstructured":"Hori M, Matsumoto M, Tanahashi N, Momomura SI, Uchiyama S, Goto S, Izumi T, Koretsune Y, Kajikawa M, Kato M, Cavaliere M, Iekushi K, Yamanaka S, Investigators JRAS. Predictive factors for bleeding during treatment with rivaroxaban and warfarin in Japanese patients with atrial fibrillation - Subgroup analysis of J-ROCKET AF. J Cardiol. 2016;68:523\u20138.","journal-title":"J Cardiol"},{"key":"2633_CR91","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.ijcard.2016.08.310","volume":"223","author":"N Kobayashi","year":"2016","unstructured":"Kobayashi N, Yamawaki M, Nakano M, Hirano K, Araki M, Takimura H, Sakamoto Y, Mori S, Tsutsumi M, Ito Y. A new scoring system (DAIGA) for predicting bleeding complications in atrial fibrillation patients after drug-eluting stent implantation with triple antithrombotic therapy. Int J Cardiol. 2016;223:985\u201391.","journal-title":"Int J Cardiol"},{"key":"2633_CR92","doi-asserted-by":"publisher","first-page":"e0160713","DOI":"10.1371\/journal.pone.0160713","volume":"11","author":"G Li","year":"2016","unstructured":"Li G, Thabane L, Delate T, Witt DM, Levine MA, Cheng J, Holbrook A. Can we predict individual combined benefit and harm of therapy? warfarin therapy for atrial fibrillation as a test case. PLoS ONE. 2016;11:e0160713.","journal-title":"PLoS ONE"},{"key":"2633_CR93","doi-asserted-by":"publisher","first-page":"e003998","DOI":"10.1161\/CIRCOUTCOMES.117.003998","volume":"11","author":"J Aisenberg","year":"2018","unstructured":"Aisenberg J, Chatterjee-Murphy P, Friedman Flack K, Weitz JI, Ruff CT, Nordio F, Mercuri MF, Choi Y, Antman EM, Braunwald E, Giugliano RP. Gastrointestinal bleeding with edoxaban versus warfarin: results from the ENGAGE AF-TIMI 48 trial (effective anticoagulation with factor Xa next generation in atrial fibrillation-thrombolysis in myocardial infarction). Circ Cardiovasc Qual Outcomes. 2018;11:e003998.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2633_CR94","doi-asserted-by":"crossref","unstructured":"Perera KS, Pearce LA, Sharma M, Benavente O, Connolly SJ, Hart RG, Committee AAS, Investigators. Predictors of mortality in patients with atrial fibrillation (from the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events [ACTIVE A]). Am J Cardiol. 2018;121:584\u2013589.","DOI":"10.1016\/j.amjcard.2017.11.028"},{"key":"2633_CR95","first-page":"A12236","volume":"140","author":"Y An","year":"2019","unstructured":"An Y, Iguchi M, Ishii M, Masunaga N, Aono Y, Ikeda S, Ishigami K, Doi K, Esato M, Tsuji H, Wada H, Hasegawa K, Ogawa H, Abe M, Akao M. Prognostic impact of anemia on stroke\/systemic embolism, bleeding, and mortality in patients with atrial fibrillation: the fushimi af registry. Circulation. 2019;140:A12236.","journal-title":"Circulation"},{"key":"2633_CR96","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1253\/circj.CJ-18-0975","volume":"83","author":"P Tiili","year":"2019","unstructured":"Tiili P, Putaala J, Mehtala J, Khanfir H, Niiranen J, Korhonen P, Raatikainen P, Lehto M. Poor quality of warfarin treatment increases the risk of all types of intracranial hemorrhage in atrial fibrillation. Circ J. 2019;83:540\u20137.","journal-title":"Circ J"},{"key":"2633_CR97","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jjcc.2018.12.003","volume":"73","author":"K Kuronuma","year":"2019","unstructured":"Kuronuma K, Okumura Y, Yokoyama K, Matsumoto N, Tachibana E, Oiwa K, Matsumoto M, Kojima T, Hanada S, Nomoto K, Arima K, Takahashi F, Kotani T, Ikeya Y, Fukushima S, Itou S, Kondo K, Chiku M, Ohno Y, Onikura M, Hirayama A, Investigators SAR. Different determinants of vascular and nonvascular deaths in patients with atrial fibrillation: a SAKURA AF Registry substudy. J Cardiol. 2019;73:210\u20137.","journal-title":"J Cardiol"},{"key":"2633_CR98","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12877-019-1051-0","volume":"19","author":"S Fu","year":"2019","unstructured":"Fu S, Jiao J, Guo Y, Zhu B, Luo L. N-terminal pro-brain natriuretic peptide levels had an independent and added ability in the evaluation of all-cause mortality in older Chinese patients with atrial fibrillation. BMC Geriatr. 2019;19:56.","journal-title":"BMC Geriatr"},{"key":"2633_CR99","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ijcard.2019.11.127","volume":"302","author":"E Kodani","year":"2020","unstructured":"Kodani E, Inoue H, Atarashi H, Okumura K, Yamashita T, Origasa H. Impact of hemoglobin concentration and platelet count on outcomes of patients with non-valvular atrial fibrillation: a subanalysis of the J-RHYTHM Registry. Int J Cardiol. 2020;302:81\u20137.","journal-title":"Int J Cardiol"},{"key":"2633_CR100","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/clc.23764","volume":"45","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Jiang C, He L, Bai Y, Wu J, Hu R, Lv Q, Ning M, Feng L, Tang R, Sang C, Long D, Dong J, Du X, Lip GYH, Ma C. Associations of anemia with death and major bleeding in patients with atrial fibrillation: a report from the Chinese Atrial Fibrillation Registry Study. Clin Cardiol. 2022;45:91\u2013100.","journal-title":"Clin Cardiol"},{"key":"2633_CR101","doi-asserted-by":"publisher","DOI":"10.1093\/ehjqcco\/qcab095","author":"N Al-Hussainy","year":"2021","unstructured":"Al-Hussainy N, Kragholm KH, Lundbye-Christensen S, Torp-Pedersen C, Pareek M, Therkelsen SK, Lip GYH, Riahi S. Safety and efficacy of direct oral anticoagulants (DOAC) in patients with anemia and atrial fibrillation: an observational nation-wide Danish cohort study. Eur Heart J Qual Care Clin Outcomes. 2021. https:\/\/doi.org\/10.1093\/ehjqcco\/qcab095.","journal-title":"Eur Heart J Qual Care Clin Outcomes"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02633-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-022-02633-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02633-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T09:04:46Z","timestamp":1668330286000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-022-02633-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,4]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2633"],"URL":"https:\/\/doi.org\/10.1186\/s12872-022-02633-6","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,4]]},"assertion":[{"value":"12 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr Lau reports that the University of Adelaide has received on his behalf lecture and\/or consulting fees from Abbott Medical, Bayer, Boehringer Ingelheim, Biotronik, Medtronic and Pfizer.\u00a0Dr Sanders reports having served on the advisory board of Medtronic, Abbott Medical, Boston Scientific, Pacemate and CathRx. Dr Sanders reports that the University of Adelaide has received on his behalf lecture and\/or consulting fees from Medtronic, Abbott Medical, and Boston Scientific. Dr Sanders reports that the University of Adelaide has received on his behalf research funding from Medtronic, Abbott Medical, Boston Scientific, and MicroPort. Dr. Wong reports that the University of Adelaide has received on his behalf lecture, travel and\/or research funding from Abbott, Bayer, Boehringer Ingelheim, Medtronic, Novartis, Servier, St Jude Medical, and Vifor Pharma.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"204"}}